Hasselt University

uhasselt.be

Total trials

203

Active

29

Phase 3

3

Total enrollment

51,305

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 0 of 0 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal

Next readouts

No upcoming readouts found.

Top conditions

  • Multiple Sclerosis32
  • Low Back Pain9
  • Heart Failure8
  • Stroke7
  • Coronary Artery Disease6
  • Lung Cancer6
  • Physical Activity5
  • Breast Cancer5

Frequently asked questions about Hasselt University

How many clinical trials does Hasselt University have on ClinicalTrials.gov?
Hasselt University is listed as the lead sponsor on 203 clinical trials in ClinicalTrials.gov, 29 of which are currently active (recruiting, enrolling, or ongoing).
How many of Hasselt University's trials are in Phase 3?
3 of Hasselt University's trials are in Phase 3.
What therapeutic areas does Hasselt University focus on?
Hasselt University's most-studied conditions on ClinicalTrials.gov are Multiple Sclerosis, Low Back Pain, Heart Failure, Stroke, Coronary Artery Disease.